by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : July 2009
AusBioPEOPLE Janssen-Cilag Australia Janssen-Cilag Australia, a company within the Johnson & Johnson family of companies, is a leading researchbased pharmaceutical company, dedicated to improving the health and well-being of all Australians. By embracing innovation, developing our people and celebrating success, we will inspire our customers with patient focused healthcare solutions. Janssen-Cilag is the seventh largest pharmaceutical company in the world. We research and develop prescription medicines for some of the world’s most serious and prevalent diseases, ranging from cancer and rheumatoid arthritis, to life-threatening bacterial infections and HIV/AIDS. Our research and development has led to the development of over 75 new drugs since our inception, including four medicines on the WHO’s Essential Drug List. Today our commitment to patients through innovation grows even stronger as we lead development in areas such as biotechnology and genomics. For further information contact: Rajesh Thakorlal, Manager – Business Development & Portfolio Planning P: 02 8875 3371 F: 02 8875 3200 E: email@example.com Moore Stephens Queensland Accounting solutions for the biotech industry McKenna Long & Aldridge LLP ‘s Life Sciences and Public Health Preparedness practice is an exciting multifaceted resource for the biotechnology sector, including emerging infectious diseases, biodefense, pandemic influenza preparedness, detection and diagnostic, decision support systems for bioterrorism response, industrial biotechnology, and personalised medicine. The Life Sciences and Public Health Preparedness team boasts well-respected professionals with a range of legal, political, governmental, scientific and business planning experience. We help secure government contracts and grants for technology offerings across the public health and life science sector as a result of access to political leaders, federal agency managers, scientific entrepreneurs, and company leaders who are spearheading the life sciences efforts. Contact Details: John Clerici Ph + 0011 (1) 202-496-7574 or firstname.lastname@example.org http://www.mckennalong.com Moore Stephens Queensland specialises in providing highly personalised, expert and commercially astute audit, accounting, tax and advisory services. We have offices in all states and New Zealand, as well as associated offices worldwide. Our Brisbane business advisory team, led by Principal, Robert Clarke and Executive, Glenn McInally, provide specialist advice to small and medium enterprises and publically listed companies. Their knowledge and experience spans across a broad spectrum of industries including biotechnology. At Moore Stephens, we can help you with: • Cost-effective audits • Corporate finance including business sales and capital raisings • Valuations of intellectual property • Taxation consulting • General business advice • Accounting and tax compliance services At Moore Stephens, we are serious about success and view our success as being solely the result of helping our clients prosper. For further information, please contact Robert Clarke – Principal Ph: (07) 3317 7877 Email: email@example.com www.moorestephens.com.au Volume 19 • Number 2 • July 2009 Australasian BioTechnology 69 Cell Therapies is a one-stop shop for cGMP manufacturing of human cells and tissue. Working with a wide range of cells we are a fully integrated supplier for clinical trials and standard of care therapies. • Nine years’ experience • FDA, TGA and EMEA compliant • >1,000 products annually • Translation from laboratory to clinic a specialty • Flexible commercial engagements • Five compliant clean rooms Raymond J Wood – Managing Director Cell Therapies Pty Ltd Ground Floor, 10 St Andrews Place East Melbourne 3002 Victoria, Australia Ph: +613 9656 1615 – Fax: +613 9656 1650 email: firstname.lastname@example.org Web: www.celltherapies.com.au